加味八珍汤影响甲状腺术后甲状旁腺功能的临床研究
Clinical Study on the Effect of Jiawei Bazhen Tang on Parathyroid Function after Thyroid Surgery
摘要: 甲状腺疾病的发病率不断升高，因手术治疗引发的并发症问题也对人们生活及社会经济带来很大的负面影响。随着“中医快速康复外科”理念的提出，中医药在围手术期的应用已经成为研究热点。减轻术后应激、缓解术后不适是快速康复的要求。中医药独特的多靶点综合调理优势，对减轻患者的痛苦、缩短患者住院时间、促进患者的康复与改善生活质量，并在临床上广泛应用及推广具有很大的价值，同时也是此次课题所研究及探讨的主要内容。
Abstract: The incidence of thyroid disorders is increasing, and the problem of complications arising from sur-gical treatment has a significant negative impact on people’s lives and socio-economics. With the concept of “Chinese medicine rapid rehabilitation surgery”, the application of Chinese medicine in the perioperative period has become a hot research topic. Reducing postoperative stress and re-lieving postoperative discomfort are requirements for rapid rehabilitation. The unique mul-ti-targeted comprehensive conditioning advantages of Chinese medicine are of great value in allevi-ating patients’ pain, shortening their hospitalization time, promoting their recovery and improving their quality of life, and are widely applied and promoted in the clinic, and are also the main content of the research and discussion of this project.
文章引用：崔箫丹, 张双元. 加味八珍汤影响甲状腺术后甲状旁腺功能的临床研究[J]. 临床医学进展, 2023, 13(12): 19753-19758. https://doi.org/10.12677/ACM.2023.13122780

参考文献

[1] Li, Y., Teng, D., Ba, J., et al. (2020) Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China. Thyroid, 30, 568-579. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[4] Li, Y., Piao, J. and Li, M. (2021) Secular Trends in the Epidemiologic Patterns of Thyroid Cancer in China over Three Decades: An Updated Systematic Analysis of Global Burden of Disease Study 2019 Data. Frontiers in Endocrinology, 12, Article ID: 707233. [Google Scholar] [CrossRef] [PubMed]
[5] Vigneri, R., Malandrino, P. and Vigneri, P. (2015) The Changing Epidemiology of Thyroid Cancer: Why Is Incidence Increasing? Current Opinion in Oncology, 27, 1-7. [Google Scholar] [CrossRef] 
[6] Affeck, B.D., Swartz, K. and Brennan, J. (2003) Surgical Considerations and Controversies in Thyroid and Parathyroid Surgery. Otolaryngologic Clinics of North America, 36, 159-180. [Google Scholar] [CrossRef] 
[7] Turner, H.E., Harris, A.L., Melmed, S., et al. (2003) Angiogenesis in Endocrine Tumors. Endocrine Reviews, 24, 600-632. [Google Scholar] [CrossRef] [PubMed]
[8] Shaha, A.R. (2008) Complications of Neck Dissection for Thyroid Can-cer. Annals of Surgical Oncology, 15, 397-399. [Google Scholar] [CrossRef] [PubMed]
[9] Asari, R., Passler, C., Kaczirek, K., et al. (2008) Hypoparathy-roidism after Total Thyroidectomy; a Prospective Study. The Archives of Surgery, 143, 132-137. [Google Scholar] [CrossRef] [PubMed]
[10] Chung, Y.L. (2003) Parathyroidectomy Hypocalcemia. Journal of the American College of Surgeons, 196, 497-498. [Google Scholar] [CrossRef] 
[11] Fewins, J., Simpson, C.B. and Miller, F.R. (2003) Compli-cations of Thyroid and Parathyroid Surgery. Otolaryngologic Clinics of North America, 36, 189-206. [Google Scholar] [CrossRef] 
[12] Sakorafas, G.H., Stafyla, V., Bramis, C., et al. (2005) Inci-dental Parathyroidectomy during Thyroid Surgery: An Underappreciated Complication of Thyroidectomy. World Journal of Surgery, 29, 1539-1543. [Google Scholar] [CrossRef] [PubMed]
[13] 彭友, 韩志江, 丁金旺, 等. 滤泡状甲状腺癌临床诊治分析[J]. 实用医学杂志, 2015, 33(9): 1497-1500.
[14] Clarke, B.L., Brown, E.M., Collins, M.T., et al. (2016) Epidemiology and Diagnosis of Hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism, 101, 2284-2299. [Google Scholar] [CrossRef] [PubMed]
[15] Giudice, M.L., Mihalik, B., Dinnyés, A., et al. (2019) The Nervous System Relevance of the Calcium Sensing Receptor in Health and Disease. Molecules, 24, Article No. 2546. [Google Scholar] [CrossRef] [PubMed]
[16] Goltzman, D., Mannstadt, M. and Marcocci, C. (2018) Physiolo-gy of the Calcium-Parathyroid Hormone-Vitamin D Axis. Vitamin D in Clinical Medicine, 50, 1-13. [Google Scholar] [CrossRef] [PubMed]
[17] Selberherr, A., Scheuba, C., Riss, P., et al. (2015) Postoperative Hypopar-athyroidism after Thyroidectomy: Efficient and Cost-Effective Diagnosis and Treatment. Surgery, 157, 349-353. [Google Scholar] [CrossRef] [PubMed]
[18] Anast, C.S., Winnacker, J.L., Forte, L.R., et al. (1976) Impaired Release of Parathyroid Hormone in Magnesium Deficiency. The Journal of Clinical Endocrinology & Metabolism, 42, 707-717. [Google Scholar] [CrossRef] [PubMed]
[19] Garrahy, A., Murphy, M.S. and Sheahan, P. (2016) Impact of Postoperative Magnesium Levels on Early Hypocalcemia and Permanent Hypoparathyroidism after Thyroidectomy. Head & Neck, 38, 613-619. [Google Scholar] [CrossRef] [PubMed]
[20] Brophy, C., Woods, R., Murphy, M.S., et al. (2019) Perioperative Magne-sium Levels in Total Thyroidectomy and Relationship to Hypocalcemia. Head & Neck, 41, 1713-1718. [Google Scholar] [CrossRef] [PubMed]
[21] 林鸿国, 黄学阳, 王建春, 等. 蔡炳勤教授治疗甲状腺疾病经验介绍[J]. 新中医, 2011, 43(12): 157-158.
[22] 陈德宁, 万力生. 中医外科临证治要[M]. 北京: 学苑出版社, 2012: 182-213.
[23] 陈志强, 谭志健. 蔡炳勤外科学术经验集[M]. 北京: 中国中医药出版社, 2013: 6-12.
[24] 黄学阳, 刘大晟, 林鸿国, 刘明, 蔡炳勤. 从病因病机探析瘿病的中医防治[J]. 中国中医基础医学杂志, 2020, 26(4): 460-462.
[25] 王梦迪, 朱见, 曹宪姣, 贺青卿. 甲状旁腺功能减退症与中医痉症的关系[J]. 外科理论与实践, 2019, 24(6): 543-545.
[26] 刘明武. 中医活血化瘀理论溯源[J]. 辽宁中医杂志, 1998, 25(11): 16-17.
[27] 白秀玲, 李秀琴. 痉症针灸治验2则[J]. 内蒙古中医药, 1995, 14(S1): 50-51.
[28] 薛红莉. 八珍汤补益气血作用研究进展[J]. 河南中医, 2010, 30(10): 1039-1041.
[29] 韩铮, 蒋科卫, 赵秉元, 李润民, 邰耀. 基于网络药理学的八珍汤治疗手术后贫血作用机制研究[J]. 中国现代中药, 2021, 23(7): 1213-1220.
[30] 彭怀仁. 二至丸、人参胡桃汤、龟鹿二仙胶考源[J]. 湖北中医杂志, 1984(5): 321.
[31] 任小银. 八珍汤对肺癌化疗致白细胞减少症患者免疫功能的影响及安全性分析[J]. 光明中医, 2021, 36(21): 3626-3628.
[32] 田好超, 李哲, 张宏军. 八珍汤在骨伤科应用研究进展[J]. 中医药临床杂志, 2019, 31(5): 981-984.
[33] 牛朝阳, 李鹏超, 孟庆良. 腰椎间盘突出症的中医诊疗思路探析[J]. 辽宁中医杂志, 2020, 47(9): 37-40.
[34] 于亚东, 刘孟军. 中药辅助微创椎间孔镜技术治疗腰椎间盘突出症的疗效及对血浆hs-CRP、CPK、IL-6水平的影响[J]. 中国中西医结合外科杂志, 2020, 26(4): 662-665.
[35] 戎珊珊, 谢凯, 沈巍, 等. 腰椎间盘突出症患者血清超敏C-反应蛋白、肿瘤坏死因子-α和白细胞介素-6在微针刀治疗前后表达水平的对比研究[J]. 中国卫生检验杂志, 2020, 30(7): 817-820.
[36] 孙钰, 杨可, 王小燕, 等. 针灸治疗腰椎间盘突出症的思路与方法[J]. 针灸临床杂志, 2018, 34(11): 1-5.
[37] 习隽丽, 石磊, 张昌欨, 等. 中医健脾法配合FOLFOX化疗方案对结肠癌术后癌因性疲乏、Th1/Th2免疫应答平衡和周围神经病变的影响观察[J]. 中华中医药学刊, 2019, 37(6): 1503-1505.
[38] 伊凡, 王子怡, 刘少康, 等. 中医药联合化疗在结直肠癌临床治疗作用中的系统评价[J]. 世界科学技术-中医药现代化, 2019, 21(2): 148-154.
[39] 李帅, 李硕. 扶正固本汤联合FOLFOX化疗对大肠癌患者术后外周血CD4+CD45RA+T水平的影响及疗效观察[J]. 世界中西医结合杂志, 2019, 14(1): 98-102.
[40] 张帆, 邸泰霖, 韩克松. 免疫球蛋白水平对术后结直肠癌复发的影响及预测价值分析[J]. 安徽医药, 2021, 25(4): 726-729.
[41] Dimberg, J., Andersson, R.E. and Haglund, S. (2020) Ge-nomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade. Oncology, 98, 575-582. [Google Scholar] [CrossRef] [PubMed]
[42] Marshall, K.M., Loeliger, J., Nolte, L., et al. (2019) Prevalence of Malnu-trition and Impact on Clinical Outcomes in Cancer Services: A Comparison of Two Time Points. Clinical Nutrition, 38, 644-651.
[43] 王丹丹, 张科. 补中固本益胃方对中晚期结肠癌根治术后化疗患者疗效及免疫平衡、血清鱼精蛋白1的影响[J]. 河北中医, 2020, 42(4): 507-511.
[44] 黄建平. 中医药在围手术期快速康复外科中的作用[J]. 上海医药, 2017, 38(8): 3-6.
[45] 陈志强. 围手术期快速康复的中医外治特色与优势[C]//中国中西医结合学会围手术期专业委员会. 第九届全国中西医结合围手术期医学专题研讨会论文集. 北京: 医药卫生科技, 2014: 7.

为你推荐